Form 8-K - Current report:
SEC Accession No. 0000950123-07-013300
Filing Date
2007-10-02
Accepted
2007-10-02 09:55:34
Documents
4
Period of Report
2007-09-28
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y40330e8vk.htm 8-K 12313
2 EX-99.1: PRESS RELEASE y40330exv99w1.htm EX-99.1 15710
3 EX-99.2: TRANSCRIPT OF WEBCAST CONFERENCE CALL y40330exv99w2.htm EX-99.2 12811
4 GRAPHIC y40330y4033000.gif GRAPHIC 9492
  Complete submission text file 0000950123-07-013300.txt   55677
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 071147715
SIC: 2835 In Vitro & In Vivo Diagnostic Substances